[High-dosage bactericidal chemotherapy in intensive care (author's transl)].
D000617:Aminoglycosides / Q000008:administration & dosage / Q000627:therapeutic use; D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000401:mortality / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007362:Intensive Care Units; D007612:Kanamycin / Q000627:therapeutic use; D010068:Oxacillin / Q000008:administration & dosage / Q000627:therapeutic use; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use; D011182:Postoperative Care; D011183:Postoperative Complications / Q000401:mortality
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010406:Penicillins; D007612:Kanamycin; D000667:Ampicillin; D010068:Oxacillin
Erfahrungen mit hochdosierter bakterizider Chemotherapie in der Intensivbehandlung. (Bericht über 519 Patienten aus den Jahren 1970 bis 1972)